Covidien

Covidien (NYSE: COV), a leading global provider of healthcare products, will present at the Bank of America Merrill Lynch 2013 Health Care Conference ... read more

Covidien (NYSE:COV) today announced 2013 full year guidance for Mallinckrodt plc as Mallinckrodt prepares to spin off from Covidien to become a separate, ... read more

Covidien (NYSE: COV), a leading global provider of healthcare products, is launching two new surgical access devices at the annual meeting of the ... read more

Covidien (NYSE: COV), a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care devices, today added ... read more

Covidien (NYSE: COV), a leading global provider of healthcare products, today announced an agreement with VIDA Diagnostics, a pioneer in quantitative pulmonary ... read more

Mallinckrodt, the Pharmaceuticals business of Covidien (NYSE: COV), today announced that it launched the 36 and 54 milligram (mg) dosage strengths of ... read more

Covidien (NYSE: COV), a leading global provider of healthcare products, will present at the Raymond James 34th Annual Institutional Investors Conference in ... read more

Covidien (NYSE: COV), a leading global provider of healthcare products, today announced the completion of patient enrollment in its iliac stent clinical ... read more

Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that Charles J. Dockendorff, Executive Vice President and Chief Financial ... read more

Covidien (NYSE:COV), a leading global provider of healthcare products, today released the results of the Solitaire™ FR Thrombectomy for Acute Revascularization (STAR) ... read more

Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that Mallinckrodt plc intends to apply to list its ordinary ... read more

Covidien (NYSE: COV), a leading global provider of healthcare products, today announced the commercial launch of the OneShot™ Renal Denervation System, an ... read more

Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that it has completed the previously announced acquisition of CV ... read more

Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that the Company’s Tri-Staple™ technology platform has achieved more than ... read more

Mallinckrodt, the Pharmaceuticals business of Covidien (NYSE: COV), today announced that it has received approval from the U.S. Food and Drug Administration ... read more

Covidien (NYSE: COV), a leading global provider of healthcare products, today announced a definitive agreement to acquire CV Ingenuity. The companies expect ... read more

Covidien (NYSE:COV), a leading global provider of healthcare products, today announced the five-year results of the ClosureFast™ Long-Term European Multi-Center Study in ... read more

Covidien (NYSE: COV), a leading global provider of healthcare products, will present at the 31st Annual J.P. Morgan Healthcare Conference in San ... read more

Covidien (NYSE: COV), a leading global provider of healthcare products, today announced a significant capacity expansion of its Kangaroo™ ePump and Kangaroo™ ... read more

Covidien, a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care devices, today announced that the ... read more